Study title:
"Ocular tolerability and safety of ketotifen fumarate ophthalmic solution.
Abelson MB, Chapin MJ, Kapik BM, Shams NB.
Adv. Ther. 2002 Jul-Aug; 19(4): 161-9
"
"Ocular tolerability and safety of ketotifen fumarate ophthalmic solution.
Abelson MB, Chapin MJ, Kapik BM, Shams NB.
Adv. Ther. 2002 Jul-Aug; 19(4): 161-9
"
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Eye Diseases
|
Brands: Please see report, Please see report, Please see report, Please see report |
MAH holders: Please see report, Please see report, Please see report, Please see report |
Assessment: |
Active substance: KETOTIFEN |
ATC code: S01GX08
|
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|